全文获取类型
收费全文 | 182886篇 |
免费 | 8048篇 |
国内免费 | 441篇 |
专业分类
耳鼻咽喉 | 2401篇 |
儿科学 | 5263篇 |
妇产科学 | 4166篇 |
基础医学 | 26573篇 |
口腔科学 | 5873篇 |
临床医学 | 11255篇 |
内科学 | 40388篇 |
皮肤病学 | 4954篇 |
神经病学 | 15531篇 |
特种医学 | 4603篇 |
外国民族医学 | 1篇 |
外科学 | 20560篇 |
综合类 | 866篇 |
一般理论 | 36篇 |
预防医学 | 21310篇 |
眼科学 | 4727篇 |
药学 | 14023篇 |
中国医学 | 722篇 |
肿瘤学 | 8123篇 |
出版年
2023年 | 1005篇 |
2022年 | 918篇 |
2021年 | 3076篇 |
2020年 | 1799篇 |
2019年 | 3405篇 |
2018年 | 5570篇 |
2017年 | 3566篇 |
2016年 | 3643篇 |
2015年 | 4093篇 |
2014年 | 4540篇 |
2013年 | 6765篇 |
2012年 | 11642篇 |
2011年 | 12353篇 |
2010年 | 6151篇 |
2009年 | 4637篇 |
2008年 | 10053篇 |
2007年 | 10712篇 |
2006年 | 10264篇 |
2005年 | 9792篇 |
2004年 | 9066篇 |
2003年 | 8471篇 |
2002年 | 7968篇 |
2001年 | 4978篇 |
2000年 | 5524篇 |
1999年 | 4252篇 |
1998年 | 880篇 |
1992年 | 2246篇 |
1991年 | 2008篇 |
1990年 | 2005篇 |
1989年 | 1700篇 |
1988年 | 1617篇 |
1987年 | 1520篇 |
1986年 | 1548篇 |
1985年 | 1460篇 |
1984年 | 1047篇 |
1983年 | 905篇 |
1979年 | 1214篇 |
1978年 | 811篇 |
1977年 | 787篇 |
1976年 | 743篇 |
1975年 | 882篇 |
1974年 | 1122篇 |
1973年 | 1171篇 |
1972年 | 1113篇 |
1971年 | 1078篇 |
1970年 | 1008篇 |
1969年 | 1083篇 |
1968年 | 1107篇 |
1967年 | 978篇 |
1966年 | 879篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Development of DNA vaccines against hemolytic-uremic syndrome in a murine model 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Capozzo AV Pistone Creydt V Dran G Fernández G Gómez S Bentancor LV Rubel C Ibarra C Isturiz M Palermo MS 《Infection and immunity》2003,71(7):3971-3978
Shiga toxin type 2 (Stx2) produced by Escherichia coli O:157H7 can cause hemolytic-uremic syndrome in children, a disease for which there is neither a vaccine nor an effective treatment. This toxin consists of an enzymatically active A subunit and a pentameric B subunit responsible for the toxin binding to host cells, and also found to be immunogenic in rabbits. In this study we developed eukaryotic plasmids expressing the B subunit gene of Stx2 (pStx2B) and the B subunit plus the gene coding for the A subunit with an active-site deletion (pStx2 Delta A). Transfection of eukaryotic cells with these plasmids produced proteins of the expected molecular weight which reacted with specific monoclonal antibodies. Newborn and adult BALB/c mice immunized with two intramuscular injections of each plasmid, either alone or together with the same vector expressing the granulocyte and monocyte colony-stimulating factor (pGM-CSF), elicited a specific Th1-biased humoral response. The effect of pGM-CSF as an adjuvant plasmid was particularly notable in newborn mice and in pStx2B-vaccinated adult mice. Stx2-neutralizing activity, evaluated in vitro on VERO cell monolayers, correlated with in vivo protection. This is the first report using plasmids to induce a neutralizing humoral immune response against the Stx2. 相似文献
992.
Phylogenetic and mathematical analyses for investigating putative mother-to-infant transmission chains when only GB virus C (hepatitis G virus) 5' noncoding region sequences are available
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
993.
Immunoglobulin M (IgM)-glycoinositolphospholipid enzyme-linked immunosorbent assay: an immunoenzymatic assay for discrimination between patients with acute toxoplasmosis and those with persistent parasite-specific IgM antibodies 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Giraldo M Portela RW Snege M Leser PG Camargo ME Mineo JR Gazzinelli RT 《Journal of clinical microbiology》2002,40(4):1400-1405
In the present study we developed an enzyme-linked immunosorbent assay (ELISA) to measure immunoglobulin M (IgM) specific for glycoinositolphospholipids (GIPL) derived from tachyzoite membrane (IgM-GIPL ELISA). The sensitivity and specificity of the assay were compared with those of commercially available Toxoplasma-specific IgM serological tests, namely, immunofluorescence assay (IFA) with fixed tachyzoites and capture ELISA employing tachyzoite extracts. Our results show that all patients with acute toxoplasmosis, as determined by clinical data and conventional serological tests, were also positive by the IgM-GIPL ELISA. Interestingly, many patients that were classified as indeterminate, who had IgG with high avidity but positive results in the IgM-specific IFA and capture ELISA, were negative by the IgM-GIPL ELISA. Finally, we tested the sera from patients with rheumatoid arthritis and various parasitic infections and found no evidence of false positives in the IgM-GIPL ELISA. 相似文献
994.
995.
Asturias JA Eraso E Arilla MC Gómez-Bayón N Inácio F Martínez A 《International archives of allergy and immunology》2002,128(2):90-96
BACKGROUND: Gastropod consumption is quite frequent in the Mediterranean countries and cross-reactivities with crustaceans have been described, but the mechanism of this allergenic cross-reactivity has not been studied in detail. This study aimed to produce recombinant Helix aspersa (brown garden snail) tropomyosin and investigate its implication for cross-reactivity among invertebrates. METHODS: A tropomyosin-specific cDNA encoding H. aspersa tropomyosin was synthetized, and recombinant allergen was overexpressed in Escherichia coli as nonfusion protein. IgE-binding reactivity was studied by immunoblotting and immunoblot inhibition experiments with sera from snail-allergic patients. RESULTS: Cloned brown garden snail tropomyosin shares high homology with other edible mollusk tropomyosins (84-69% identity) as well as with those from arthropods (65-62%), and less homology with vertebrate ones (56% identity). Tropomyosin reacted with 18% of the sera from patients with snail allergy. Inhibition experiments, using natural and recombinant tropomyosins, showed different degrees of cross-reactivity between invertebrate tropomyosins. Sera from snail-allergic subjects recognized tropomyosins in both mollusks and crustacean extracts. CONCLUSIONS: Tropomyosin represents a minor allergen in snail extracts, but it is clearly involved in invertebrate cross-reactivity. 相似文献
996.
Donís-Hernández FR Parkhouse RM Santos-Argumedo L 《European journal of immunology》2001,31(4):1261-1267
Analysis of expression of CD38, CD45R (B220), IgM and IgD on splenic B lymphocytes from mice of different ages demonstrated CD38 on both immature (B220(+), BCR(-)) and mature (B220(+), BCR(+)) B lymphocytes. Similarly, CD38 is expressed as early as B220 on the surface of progenitor B cells in the bone marrow. In spite of expressing of CD38 and IgM, neonatal B cells, in contrast to the adult, failed to proliferate to either anti-CD38 or anti-IgM cross-linking when IL-4 was present. They did, however, respond to LPS and anti-CD40, and by 2 weeks of age they began to respond to anti-CD38 and anti-IgM, reaching adult B cell levels by 4 weeks. Although the distribution of CD38 on adult B cells from most different lymphoid compartments was broadly similar, significantly higher levels of CD38 were expressed on peritoneal B lymphocytes. A detailed analysis, using IgM / IgD ratio and staining with anti-CD5 confirmed that B1 lymphocytes were expressing a high level of CD38. Interestingly, both immature B cells and peritoneal B1 lymphocytes were unresponsive to anti-CD38. However, they were activated by LPS or anti-CD40. 相似文献
997.
998.
Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma 总被引:30,自引:0,他引:30
Máximo V Soares P Seruca R Rocha AS Castro P Sobrinho-Simões M 《Genes, chromosomes & cancer》2001,32(2):136-143
Mitochondrial DNA (mtDNA) large deletions and mtDNA mutations have been demonstrated in various types of human cancer. The relationship between the occurrence of such alterations and the nuclear microsatellite instability (MSI) status of the neoplastic cells remains controversial. In an attempt to clarify the situation in gastric carcinoma, we studied, by PCR/SSCP and sequencing, five mitochondrial genes and two D-loop regions in 32 gastric carcinomas that had been previously screened for MSI and mitochondrial common deletion. MtDNA alterations were detected in 26 carcinomas (81%). All the mtDNA mutations, which occurred mainly in the D-loop and ND1 and ND5 genes, were transitions. D-loop alterations (insertions and/or deletions) were not significantly associated with mutations in the coding regions. There was a trend towards an inverse relationship between the occurrence of mitochondrial common deletion and mtDNA mutations. No significant relationship was observed between MSI status and mtDNA mutations, whereas the mitochondrial common deletion appeared to be almost exclusively restricted to MSI-negative tumors. The latter finding--almost no gastric carcinoma with MSI-positive phenotype has large deletions of mtDNA--needs to be confirmed in a larger series and in tumors from other organs. 相似文献
999.
A 51-year-old woman was admitted for a painless enlargement of the thyroid lasting over 6 months. Hashimoto's thyreoiditis was diagnosed and three tumors were found: oncocytic carcinoma, malignant lymphoma and papillary carcinoma. In the right lobe, oncocytic carcinoma and high grade malignant lymphoma composed of cells with irregular, lobulated nuclei were found. The lymphoma was confined to the thyroid gland. The oncocytic carcinoma invaded the capsule and the surrounding tissues. In the left lobe, there was a papillary carcinoma. 相似文献
1000.
Inogés S Merino J Bandrés E De Castro P Subirá ML Sánchez-Ibarrola A 《Clinical and experimental immunology》1999,115(3):521-525
In this study we have examined intracellular cytokines in peripheral blood mononuclear cells (PBMC) of MS patients by flow cytometry (cytokine flow cytometry). MS progressive patients showed an increased number of cells producing interferon-gamma (IFN-gamma) after activation with phorbol 12-myristate 13-acetate and ionomycin, compared with patients with clinically inactive forms (P < 0001) and with healthy controls (P = 0001). These cells belonged to the CD4+ and CD8+ subsets in similar proportions. Clinically inactive patients showed a lower level of cells producing IL-2 than controls (P = 0.03) and active MS patients (P = 0.03). Most IL-2-producing cells were CD4+ lymphocytes, although a small part of the IL-2 was also produced by CD8+ cells. The percentage of cells producing simultaneously IL-2 and IFN-gamma was increased in active MS and they were mainly CD4+ lymphocytes. No differences in the production of IL-4 were observed between groups. However, we found an increased IL-10 production in clinically active MS patients (P = 0.03). Treatment with IFN-beta of active MS patients showed lower levels of cytokines when compared with untreated MS patients. This methodological approach could help in the follow up and therapeutic monitoring of MS patients. 相似文献